OncoTargets and Therapy

OncoTargets and Therapy is an open-access peer-reviewed journal covering the molecular diagnosis of cancer and targeted molecular or precision therapy, published by Dove Medical Press and established in 2008, with a 2025 impact factor of 2.4（OncoTargets and Therapy）是由 Dove Medical Press 出版、2008 年创刊的开放获取同行评审期刊，聚焦肿瘤的分子诊断与靶向分子或精准治疗，2025 年影响因子为 2.4。

Scope

• The molecular diagnosis of cancer肿瘤的分子诊断。
• Targeted molecular and precision therapy for all types of cancer面向各类癌症的靶向分子与精准治疗。
• Basic, clinical and translational research on new and existing therapies针对新疗法与现有疗法的基础、临床与转化研究。
• Evidence that supports informed acceptance of therapies by clinicians and treatment adherence by patients支持临床医生知情采纳疗法、患者坚持治疗的证据。
• Work aimed at clinicians, researchers and medical oncologists面向临床医生、研究人员与肿瘤内科医师。

History

• The journal was launched in 2008 by Dove Medical Press of Auckland, New Zealand, its first volume appearing that year该刊 2008 年由新西兰（Auckland）的 Dove Medical Press 创办，当年出版第 1 卷。
• Articles are published continuously as they are accepted and are later collected into annual volumes文章随录随发，之后结集成年度卷。
• As an open-access title its articles are free to read, with costs met by article processing charges作为开放获取刊物，其文章可免费阅读，费用由文章处理费承担。
• It is indexed in Science Citation Index Expanded, PubMed, Scopus, DOAJ and Embase, and is a member of COPE该刊被 SCIE、PubMed、Scopus、DOAJ 与 Embase 收录，并为（COPE）成员。

Editors

• The editor-in-chief is Professor Gaetano Romano现任主编为 Gaetano Romano 教授。
• The journal is overseen by an international editorial board of oncology specialists该刊由肿瘤学专家组成的国际编委会负责。
• Manuscripts are peer reviewed, and the journal follows the principles of the Committee on Publication Ethics稿件经同行评审，期刊遵循出版伦理委员会的原则。
• Accepted papers are published online without a fixed issue schedule录用稿件即在线发表，不受固定刊期限制。